相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns
Zi-Li Yu et al.
NPJ PRECISION ONCOLOGY (2022)
Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms
Abdollah Jafarzadeh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki et al.
CELL (2021)
T Cells: Warriors of SARS-CoV-2 Infection
Paola de Candia et al.
TRENDS IN IMMUNOLOGY (2021)
Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses
Hui Feng et al.
PLOS PATHOGENS (2021)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa et al.
CELL (2021)
Epithelial response to IFN-γ promotes SARS-CoV-2 infection
Julian Heuberger et al.
EMBO MOLECULAR MEDICINE (2021)
SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry
Rose K. C. Moritz et al.
EUROPEAN JOURNAL OF CANCER (2021)
Interferon-inducer antivirals: Potential candidates to combat COVID-19
Ashkan Bagheri et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma
Tadashi Shiraishi et al.
ONCOLOGY (2021)
Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19
Jiezhong Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
Mario Mandala et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
Angelo Dipasquale et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
Jessica Sook Yuin Ho et al.
CELL (2021)
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
Hsiang-Chi Huang et al.
EBIOMEDICINE (2021)
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
Maria Antonietta Isgro et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut
Sergio Triana et al.
MOLECULAR SYSTEMS BIOLOGY (2021)
Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective
Seyed Hootan Hamidi et al.
PHARMACOLOGICAL REPORTS (2021)
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself
Marta Ferreira-Gomes et al.
NATURE COMMUNICATIONS (2021)
Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic
Nitin Saksena et al.
FRONTIERS IN GENETICS (2021)
The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication
Benjamin E. Nilsson-Payant et al.
JOURNAL OF VIROLOGY (2021)
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
Cheng-Pu Sun et al.
PLOS PATHOGENS (2021)
The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes
Tasnim H. Beacon et al.
CLINICAL EPIGENETICS (2021)
Neutrophils in the era of immune checkpoint blockade
Julien Faget et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan et al.
INFLAMMOPHARMACOLOGY (2021)
Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae Seok Kim et al.
THERANOSTICS (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
Mahmoud Gheblawi et al.
CIRCULATION RESEARCH (2020)
IL-6: Relevance for immunopathology of SARS-CoV-2
E. O. Gubernatorova et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
Ka Shing Cheung et al.
GASTROENTEROLOGY (2020)
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Melissa Bersanelli
IMMUNOTHERAPY (2020)
Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
Vincenzo Di Noia et al.
LUNG CANCER (2020)
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Ricardo J. Jose et al.
LANCET RESPIRATORY MEDICINE (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
COVID-19 and cancer: what we know so far
Peter Sidaway
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
Amr H. Sawalha et al.
CLINICAL IMMUNOLOGY (2020)
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
Bakiye Goker Bagca et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Victor J. Costela-Ruiz et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic
Silke Gillessen et al.
EUROPEAN UROLOGY (2020)
Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
Sonu Bhaskar et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
Wenjie Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Benjamin Israelow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
Bruna G. G. Pinto et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic
Hsu-Liang Chang et al.
LUNG CANCER (2020)
Expanded encyclopaedias of DNA elements in the human and mouse genomes
Jill E. Moore et al.
NATURE (2020)
Determinants of COVID-19 disease severity in patients with cancer
Elizabeth V. Robilotti et al.
NATURE MEDICINE (2020)
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Andrew D. Davidson et al.
GENOME MEDICINE (2020)
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy
Cesar Martins da Costa et al.
IMMUNOTHERAPY (2020)
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome
Lila Bouadma et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2020)
A Granulocytic Signature Identifies COVID-19 and Its Severity
Joana Vitte et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
The epigenetic implication in coronavirus infection and therapy
Sandra Atlante et al.
CLINICAL EPIGENETICS (2020)
Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection
Jiya Sun et al.
FRONTIERS IN MICROBIOLOGY (2020)
Regulation of PD-L1 Expression by NF-κB in Cancer
Fabrizio Antonangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Ralf Kircheis et al.
FRONTIERS IN IMMUNOLOGY (2020)
PD-L1 degradation pathway and immunotherapy for cancer
Qian Gou et al.
CELL DEATH & DISEASE (2020)
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Ke Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?
Hubert Hondermarck et al.
FASEB BIOADVANCES (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi et al.
IMMUNE NETWORK (2020)
Comparative transcriptomics method to infer gene coexpression networks and its applications to maize and rice leaf transcriptomes
Yao-Ming Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
Chia-Wei Li et al.
CANCER CELL (2018)
ISG15 in antiviral immunity and beyond
Yi-Chieh Perng et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Soluble immune checkpoints in cancer: production, function and biological significance
Daqian Gu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
AAV vector distribution in the mouse respiratory tract following four different methods of administration
Lisa A. Santry et al.
BMC BIOTECHNOLOGY (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells
Shasha Song et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
PD-1 as a potential target in cancer therapy
David F. McDermott et al.
CANCER MEDICINE (2013)
Differential expression in RNA-seq: A matter of depth
Sonia Tarazona et al.
GENOME RESEARCH (2011)
Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients With Myelofibrosis
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2011)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
ChIP-seq: advantages and challenges of a maturing technology
Peter J. Park
NATURE REVIEWS GENETICS (2009)
Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3′-diindolylmethane in Sprague-Dawley rats
DA Leibelt et al.
TOXICOLOGICAL SCIENCES (2003)